TY - JOUR
T1 - Activation and identification of a griseusin cluster in streptomyces sp. Ca-256286 by employing transcriptional regulators and multi-omics methods
AU - Beck, Charlotte
AU - Gren, Tetiana
AU - Ortiz-López, Francisco Javier
AU - Jørgensen, Tue Sparholt
AU - Carretero-Molina, Daniel
AU - Serrano, Jesús Martín
AU - Tormo, José R.
AU - Oves-Costales, Daniel
AU - Kontou, Eftychia E.
AU - Mohite, Omkar S.
AU - Mingyar, Erik
AU - Stegmann, Evi
AU - Genilloud, Olga
AU - Weber, Tilmann
N1 - Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021
Y1 - 2021
N2 - Streptomyces are well-known producers of a range of different secondary metabolites, including antibiotics and other bioactive compounds. Recently, it has been demonstrated that “silent” biosynthetic gene clusters (BGCs) can be activated by heterologously expressing transcriptional regulators from other BGCs. Here, we have activated a silent BGC in Streptomyces sp. CA-256286 by overexpression of a set of SARP family transcriptional regulators. The structure of the produced compound was elucidated by NMR and found to be an N-acetyl cysteine adduct of the pyranonaphtoquinone polyketide 3′-O-α-D-forosaminyl-(+)-griseusin A. Employing a combination of multi-omics and metabolic engineering techniques, we identified the responsible BGC. These methods include genome mining, proteomics and transcriptomics analyses, in combination with CRISPR induced gene inactivations and expression of the BGC in a heterologous host strain. This work demonstrates an easy-to-implement workflow of how silent BGCs can be activated, followed by the identification and characterization of the produced compound, the responsible BGC, and hints of its biosynthetic pathway.
AB - Streptomyces are well-known producers of a range of different secondary metabolites, including antibiotics and other bioactive compounds. Recently, it has been demonstrated that “silent” biosynthetic gene clusters (BGCs) can be activated by heterologously expressing transcriptional regulators from other BGCs. Here, we have activated a silent BGC in Streptomyces sp. CA-256286 by overexpression of a set of SARP family transcriptional regulators. The structure of the produced compound was elucidated by NMR and found to be an N-acetyl cysteine adduct of the pyranonaphtoquinone polyketide 3′-O-α-D-forosaminyl-(+)-griseusin A. Employing a combination of multi-omics and metabolic engineering techniques, we identified the responsible BGC. These methods include genome mining, proteomics and transcriptomics analyses, in combination with CRISPR induced gene inactivations and expression of the BGC in a heterologous host strain. This work demonstrates an easy-to-implement workflow of how silent BGCs can be activated, followed by the identification and characterization of the produced compound, the responsible BGC, and hints of its biosynthetic pathway.
KW - Biosynthetic gene cluster
KW - Forosamine
KW - Genome mining
KW - Griseusin
KW - Heterologous expression
KW - Mycothiol
KW - Pyranonaphtoquinone
KW - Transcriptional regulators
U2 - 10.3390/molecules26216580
DO - 10.3390/molecules26216580
M3 - Journal article
C2 - 34770989
AN - SCOPUS:85118398151
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
M1 - 6580
ER -